Clinical Trial Update: New Oral Sleep Apnea Drug Completes Phase 2 Dosing

Clinical Trial Update: New Oral Sleep Apnea Drug Completes Phase 2 Dosing

Incannex Healthcare (NASDAQ: IXHL) has completed patient dosing…

Continue Reading
Incannex Healthcare Inc. Provides Clinical Program Update on IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)

Incannex Healthcare Inc. Provides Clinical Program Update on IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)

Patient dosing completed in Phase 2 portion of Phase 2/3 RePOSA study evaluating IHL-42X oral treatment…

Continue Reading
Shaping the Future of Sleep Apnea Diagnostics with Wearables

Shaping the Future of Sleep Apnea Diagnostics with Wearables

R. Kirk Huntsman, Chairman and CEO, Co-Founder at Vivos Therapeutics Sleep is essential, yet millions worldwide…

Continue Reading
Health service use more likely with sleep apnea in older patients

Health service use more likely with sleep apnea in older patients

Add topic to email alerts Receive an email when new articles…

Continue Reading
Resolute Health Appoints New Leader to Drive Growth in Sleep Apnea Care

Resolute Health Appoints New Leader to Drive Growth in Sleep Apnea Care

Summary: Resolute Health Corp Ltd, a Canadian sleep apnea testing and treatment provider, has appointed Heather…

Continue Reading
Erie-area woman beats sleep apnea with implantable inspire device

Erie-area woman beats sleep apnea with implantable inspire device

Lisa Sharpless’ sleep apnea was so severe that her husband, Jim, would lie awake in bed…

Continue Reading